Iterum Therapeutics plc (ITRM )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol ITRM
- Company Iterum Therapeutics plc
- Price $0.03
- Changes Percentage -55.97
- Change -0.0394
- Day Low $0.03
- Day High $0.05
- Year High $1.42
- Year Low $0.03
- Market Cap $1,652,039
- Price Avg 50 EMA (D) $0.24
- Price Avg 200 EMA (D) $0.56
- Exchange NASDAQ
- Volume 43,661,088
- Average Volume 15,483,346
- Open $0.04
- Previous Close $0.07
- EPS -0.72
- PE -0.04
- Earnings Announcement 2026-03-31 12:30:00
- Shares Outstanding $53,291,578
Company brief: ITERUM THERAPEUTICS PLC (ITRM )
- Healthcare
- Biotechnology
- Mr. Corey N. Fishman
- https://www.iterumtx.com
- IE
- N/A
- 05-25-2018
- IE000TTOOBX0
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
ITRM Corporation News
Iterum files wind-up petition due to limited cash, inability to raise equity
reuters.com -- Iterum Therapeutics said on Friday it has filed a petition in Ireland's High Court to wind up the drugmaker and was placed into provisional liquidation, with a hearing set for April 13....
Iterum Therapeutics Announces Filing of Winding Up Petition
globenewswire.com -- DUBLIN and CHICAGO, March 27, 2026 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (in Provisional Liquidation) (Nasdaq: ITRM) (the “Company” or “Iterum” or “we”), a company focused on deliver...